Results 1 to 10 of about 5,883,314 (302)

Association between insulin resistance and sustained virologic response in hepatitis C treatment, genotypes 1 versus 2 and 3: systematic literature review and meta-analysis

Brazilian Journal of Infectious Diseases, 2013
Background/aims: Controversial results have been found in literature for the association between insulin resistance and sustained virologic response to standard chronic hepatitis C treatment. This study aims to provide a systematic literature review with
Marcela Pezzoto Laurito, Edison Roberto Parise   +1 more
doaj   +6 more sources

Frequency of Sustained Virologic Response in Hepatitis C Positive, Treatment Naïve Patients on Sofosbuvir and Daclatasvir [PDF]

Journal of Gandhara Medical and Dental Sciences, 2023
OBJECTIVES To measure the frequency of sustained virologic response in Hepatitis C positive, treatment naïve patients on Sofosbuvir and Daclatasvir.
Islam Shah, Nayab Munib, Aliena Badshah, Wazir Mohammad   +3 more
doaj   +2 more sources

Adherence and sustained virologic response among vulnerable people initiating an hepatitis C treatment at a nurse-led clinic: A non-experimental prospective cohort study based on clinical records

International Journal of Nursing Studies Advances, 2021
Background: There is a need to develop specific care route for vulnerable people with hepatitis C virus. Objective: At a nurse-led clinic, we aimed to: (1) report the prevalence of patients initiating an hepatitis C treatment who (a) achieved sustained ...
Myriam Gagné, Isabelle Têtu, Jean-Pierre Grégoire, Jocelyne Moisan   +3 more
doaj   +1 more source

Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report

Journal of Medical Case Reports, 2020
Background Combination therapy of interferon and ribavirin has traditionally been used to eradicate hepatitis C virus. The sustained virologic response achieved with interferon-related therapy is persistent, and late relapses after achieving sustained ...
Ken Kurokawa, Takamasa Ohki, Jun Kato, Yukiyo Fukumura, Makoto Imai, Chikako Shibata, Junya Arai, Mayuko Kondo, Kaoru Takagi, Kentaro Kojima, Michiharu Seki, Masaya Mori, Nobuo Toda, Kazumi Tagawa   +13 more
doaj   +1 more source

IMPACT OF DIABETIC CONTROL ON ACHIEVING SUSTAINED VIROLOGIC RESPONSE IN CHRONIC HCV PATIENTS RECEIVING DIRECT-ACTING ANTIVIRALS [PDF]

Journal of the Egyptian Society of Parasitology, 2018
This study evaluated the effect of diabetic control on achieving sustained virologic response in patients with chronic hepatitis C virus infection who received direct-acting antivirals (Daclatasvir + Sofosbuvir ± Ribavirin). It included 100 patients with
AHMED MOHAMMED, AYMAN GAMIL, REHAM AL-SWAFF, KHALED ELKARMOUTY   +3 more
doaj   +1 more source

Sofosbuvir-velpatasvir en pacientes mexicanos con hepatitis C: una revisión retrospectiva

Revista de Gastroenterología de México, 2022
Resumen: Introducción: La combinación de sofosbuvir-velpatasvir (SOF/VEL) es una terapia antiviral de acción directa que está autorizada y disponible en México.
J.L. Pérez-Hernández, C.A. Arce-Salinas, R. Lehmann-Mendoza, A. Torre-Delgadillo, G.E. Castro-Narro, E. Cerda-Reyes, M.V. Ramos-Gómez, L. Juárez-Chavez, M. Dehesa-Violante, L.E. Muñoz-Espinosa, L.E. Cisneros-Garza, I. Aiza-Haddad, J.A. Velarde-Ruiz-Velasco, R. Contreras-Omaña, N. García-Casarreal, A. Carmona-Castañeda, F. Higuera-De la Tijera   +16 more
doaj   +1 more source

Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study [PDF]

The Korean Journal of Internal Medicine, 2020
Background/Aims We aimed to assess the role of vitamin D supplementation in the response to pegylated interferon-α (PEG-IFN-α) plus ribavirin (RBV) treatment in patients with chronic hepatitis C (CHC).
Jae Yoon Jeong, Dae Won Jun, Sol Ji Park, Joo Hyun Sohn, Sang Gyune Kim, Se Whan Lee, Soung Won Jeong, Moon Young Kim, Won Kim, Jae-Jun Shim, Hyoung Su Kim, Ki Tae Suk, Sang Bong Ahn   +12 more
doaj   +1 more source

The Combination Therapy with Peg-interferon Alfa and Ribavirin for Chronic Hepatitis C in Korea as an Initial Treatment [PDF]

Kosin Medical Journal, 2012
Objectives The combination therapy with peginterferon and ribavirin has been used to treat chronic hepatitis C for several years in Korea but there is a few report about the results of the treatment.
Dong Hyun Park, Sang Uk Lee, Jin Seok Yu, Jun Seop Lee, Hye Jung Kwon   +4 more
doaj   +1 more source

Safety and effectiveness of direct-acting antivirals in patients with chronic hepatitis C and chronic kidney disease [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims To evaluate the effectiveness and safety of direct acting antivirals (DAAs) available in chronic kidney disease (CKD) patients with hepatitis C virus (HCV) infection in Korea.
Ji Eun Ryu, Myeong Jun Song, Seok-Hwan Kim, Jung Hyun Kwon, Sun Hong Yoo, Soon Woo Nam, Hee Chul Nam, Hee Yeon Kim, Chang Wook Kim, Hyun Yang, Si Hyun Bae, Do Seon Song, U Im Chang, Jin Mo Yang, Sung Won Lee, Hae Lim Lee, Soon Kyu Lee, Pil Soo Sung, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon   +20 more
doaj   +1 more source

GAMMA GLUTAMYLTRANSFERASE IMPACT IN THERAPEUTIC RESPONSE OF CHRONIC HEPATITIS C: a systematic review of the literature

Arquivos de Gastroenterologia, 2015
BackgroundThe standard treatment of chronic hepatitis C is the administration of pegylated interferon α2a or α2b in combination with ribavirin, but adverse effects can be observed, as well as the high cost of this therapy. Therefore, there is interest in
Maria de Lourdes Albuquerque de QUEIROGA, Raymundo PARANÁ, José Eymard Moraes de MEDEIROS FILHO, Giovannini Cesar A FIGUEIREDO, Ananda Peixoto de ARAÚJO, Hagley Walson Soares LEITE, Itiel de Souza AQUINO, Leonardo Honório de A MELO NETO   +7 more
doaj   +1 more source